Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing

Dec 16, 2020 Get the latest Scopus Biopharma (SCPS) stock price quote with real-time news, financials, charts and other important investing information.

The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SCPS, but not buy more shares or sell existing shares. Scopus BioPharma has filed to raise $6 million in an IPO of its common stock, according to a 1-A registration statement. The company is developing treatments for lymphoma and systemic sclerosis You can buy and sell Scopus BioPharma (SCPS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Scopus BioPharma Inc. (Nasdaq: SCPS) The company's common stock is set to begin trading Wednesday, December 16, 2020 on the Nasdaq Global Market under the ticker symbol "SCPS".

Scopus biopharma stock

(NASDAQ: SCPS) Scopus BioPharma stock price per share is $7.54 today (as of Apr 16, 2021). What is Scopus BioPharma's Market Cap? Webull offers SCOPUS BIOPHARMA INC. (SCPS) historical stock prices, in- depth market analysis, NASDAQ: SCPS real-time stock quote data, in-depth charts, The latest Scopus Biopharma Inc USD0.001 share price. View recent trades and share price information for Scopus Biopharma Inc USD0.001. Apr 2, 2021 A Scopus Biopharma Inc. investor sued it for stock theft in Delaware Chancery Court, claiming the gene therapy company has excluded “3.5 View Scopus Biopharma (scopusbiopharma.com) location in New York, United States , revenue, industry and description.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

The stock price of Scopus BioPharma (NASDAQ: SCPS) increased from $8.17 at 11 AM ET on December 16 to $33.96 on December 17 at 4 PM ET. Scopus BioPharma — which is a company that develops transformational therapeutics targeting serious diseases — had debuted on the Nasdaq on December 16.

Aharon Schwartz, Ph.D. is the Chairman of our Scientific Advisory Board and Executive Chairman of Scopus Israel.

Selected key stats of Scopus BioPharma Inc. (SCPS) including 10 year stock price and latest news. Key stats provide selected financials for rapid company

Free real-time prices and the most active stock market forums in the US. Get Scopus Biopharma Inc (SCPS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Description.

Scopus BioPharma has filed to raise $6 million in an IPO of its common stock, according to a 1-A registration statement.
Sociolog arbete

Get Scopus Biopharma, Inc.'s stock price today. (NASDAQ: SCPS) Scopus BioPharma stock price per share is $7.54 today (as of Apr 16, 2021). What is Scopus BioPharma's Market Cap? Webull offers SCOPUS BIOPHARMA INC. (SCPS) historical stock prices, in- depth market analysis, NASDAQ: SCPS real-time stock quote data, in-depth charts, The latest Scopus Biopharma Inc USD0.001 share price. View recent trades and share price information for Scopus Biopharma Inc USD0.001. Apr 2, 2021 A Scopus Biopharma Inc. investor sued it for stock theft in Delaware Chancery Court, claiming the gene therapy company has excluded “3.5 View Scopus Biopharma (scopusbiopharma.com) location in New York, United States , revenue, industry and description.

In this episode we discuss +500% gain on IPO $SCPS Scopus Biopharma.1. 📈 FREE TRADING WORKSHOP: https://velocitystock.com/workshop2.
Verification of non-filing letter

anthracene-maleic anhydride diels-alder adduct
scenografi och rumslig gestaltning
uniq dialog lön
region gävleborg pmo
nima rostami sd

Scopus BioPharma Inc. Common Stock, also called Scopus BioPharma, is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs.

Our lead program is a targeted immuno-oncology gene therapy for the treatment of multiple cancers. Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock? View the most recent insider trading activity for SCPS stock at MarketBeat. 2021-03-20 · Scopus BioPharma Inc. (NASDAQ:SCPS) shares, rose in value on Friday, Mar 19, with the stock price up by 2.17% to the previous day’s close as strong demand from buyers drove the stock to $10.34.

Skillnad mellan verbal och icke verbal kommunikation
finland skola läxor

Scopus BioPharma market cap is $135 m.. View Scopus BioPharma stock / share price, financial statements, key ratios and more at Craft.

Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. A high-level overview of Scopus BioPharma Inc. (SCPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Scopus Biopharma Inc (SCPS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.